http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009077736-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79a2d4bdad30206343ed91ac3a807889
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
filingDate 2008-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbff35c0fa938a2b31dfff8e92a987a7
publicationDate 2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009077736-A4
titleOfInvention A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
abstract A medicament for topical administration to a human or animal eye comprises at least two pharmacologically active agents. One of the active agents is a parasympathetic agonist, such as pilocarpine, and the other active agent is either a sympathetic antagonist such as dapiprazole or thymoxamine, or a sympathetic agonist such as brimonidine or iopidine. The medicament is preferably in the form of a liquid composition, such as eye drops, or a gel or ointment and may comprise a slow-release composition. The medicament acts to improve visual acuity for a period of several hours, and may be beneficial in cases of presbyopia, myopia, hypermetropia, astigmatism and/or impaired night vision.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9579308-B2
priorityDate 2007-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226776033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57116374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226970533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414161244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226517331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500728

Total number of triples: 45.